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Abstract 
Background: Hepatotoxicity is a common problem in medical practice, most of the 
commonly used drugs are potentially hepatotoxic. Although Methotrexate is a hepa- 
toxic drug, it is widely used in the treatment of many cancerous and non-cancerous 
conditions because of its cytotoxic and immunosuppressant activity. Curcumin con- 
tains a variety of natural substances with antioxidant properties, it is widely used in  
folk medicine.Antioxidant activity of Curcumin can reduce liver cell injury induced by 
Methotrexate administration. 
Objective: The research aims to study the methotrexate hepatoxicity on rabbits, and the 
hepatoprotective activity of Curcumin. 
Materials and Methods: Thirty white domestic rabbits were bought from animal 
market and grouped randomly into three groups; control group received intraperitoneal 
normal saline, methotrexate group received 6.5 mg/Kgm body weight intraperitoneal 
methotrexate, and curcumin group received oral Curcumin in addition to intraperitoneal 
methotrexate. 
Results: The study showed abnormal liver function tests, INR, liver tissues oxida- tive 
markers, and liver cell injury on histopathology in Methotrexate group, and normal 
findings in Curcumin groups. 
Conclusion: It is concluded that the Methotrexate is a hepatotoxic drug. The results 
also shoe that the concomitant administration of Curcumin reduced hepatotoxicity. 
Recommendation: It is recommended to use of Curcumin in clinical practice as a food 
supplement to patient receiving methotrexate to reduce hepatotoxicity. 
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1 -Introduction 
Methotrexate (MTX) is a widely used immunosuppressant and anticancer Drug [1]. It 
is used in clinical practice against variety of neoplastic and non-neoplastic diseases 
especially autoimmune diseases like systemic lupus erythematosus, psoriasis,  
inflammatory bowel diseases,  and rheumatoid arthritis [2] [3] [4] [5] [6].  
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Methotrexate is  a folic acid antagonist because of its folic acid reeducates inhibitory 
capability ,its chemical structure is (4-amino-N10-methyl folic acid), and its anti-cancer 
activity is due to inhibition of DNA synthesis resulting in blocking of cell proliferation 
[7]. Cytotoxic activity of MTX is extended to affect cells of vital organs especially the 
bone marrow, gastrointestinal mucosal cells, liver, kidneys, and hair follicle cells in 
addition to tumor cells [8]. Methotrexate affects in particularly, most actively growing 
cells [9] [10]. It can’t distinguish between actively growing cancer and normal body cells, 
so treatment with MTX results in alopecia and pancytopenia because of elimination of 
fast growing normal body cells such as hair and blood forming cells in hair root and bone 
marrow [11] [12]. Hepatotoxicity induced by MTX is thought to be the result of oxidative 
stress formed by generation of reactive oxygen species (ROS) in parenchymal liver cells 
and depletion of parenchymal liver cells from its natural antioxidant defense mechanisms 
[11] [13].Superoxide dismutase (SOD) in mitochondria converts superoxide (0−2)to 
H202, and Glutathione peroxidase (GPx) in mitochondria converts hydroxyl ion(0H−)into 
H202 [13]. Therefore, measurement of SOD and GSH in liver tissue homogenate by 
ELIZA is an indirect estimate of the level of ROS and oxidative stress in liver cell 
parenchyma [13].Curcuminis derived from the perennial herb“Curcuma longa” [14]. 
Curcumin is a yellow-colored spice well known for its anti-cancer and anti-oxidant 
properties,and it is widely used in folk and traditional medicine for centuries in the 
treatment of variety of diseases such as liver disorders, hepatitis, cancer, inflammatory 
disorders, rheumatoid arthritis, skin diseases, and Alzheimer’s disease [15] [16]. 
Curcumin can reduce ROS formed during oxidative stress by lessen regulation of nitric 
oxide synthetase (NOS) activity in macrophages [16], which synthesizes nitric oxide 
(NO) during ’oxidative burst’ necessary in defense against pathogens. The present study 
was designed to study of methotrexate-induced  hepatoxicity  on  Iraqi  white  domestic  
rabbits,   and  the  hepato-protective activity of Curcumin. 
 
2 -MATERIALS  AND METHODS 
3 -Animals 
Thirty healthy male white domestic Iraqi rabbits of age 5 to 6 months, and weighing 
between 1.5 and 2 Kg were obtained from Baghdad animal market. Rabbits were ran- 
domly divided into three experimental groups of 10 rabbits each and rabbits were labeled. 
The experimental groups were; the control group, Methotrexate group, and Curcumin 
group. Every three animals were housed in one cage, and standard conditions of tem- 
perature, humidity, and 12 hrs. light/dark cycles were maintained in all the cages, and 
during the whole experiment. The experimental protocol was approved by Ethical Com- 
mittee at Almustansiriyah College of Medicine. Animals were fed with normal diet and 
left for 72 hrs. to be acclimatized to the facility before starting the study.The study was 
conducted between December 2016 and February 2017 at the Department of Pathology, 
Al-mustansiriyah College of Medicine.The experiment duration was seven days. 
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4 -Experimental Design 
5 -Control group 
Members of this group received during the whole period of experiment 3ml, of 
normal saline intraperitoneally every day and fed normal diet. This group serves as a 
negative control for other two groups. 
 
6 -Methotrexate group 
Members of this group during the whole period of experiment received 6.5mg/Kgm 
body weight methotrexate (from medac Pharma company) intraperitoneally as a single 
daily dose to induce hepatotoxicityand fed with normal diet. 
 
7 -Curcumin group 
Members of this group during the whole period of experiment received 6.0 gm/Kgm 
body weight curcumin daily orally dissolved in distilled waterin three divided 
dosesusing ani- mal feeding tube,in addition to the daily dose of 6.5 mg/Kgm body weight 
of methotrexate intraperitoneally, and they also received a normal diet. 
8 -Methodology 
9 -Labelling and weighing of  rabbits 
Before starting the experiment, the animals were labelled and the weight of each was 
taken and recorded to adjust doses of drugs accordingly. 
 
10 -Administration  of drugs 
Drugs were given from day-1 to day-7 of experiment per weight and experimental 
design. 
 
11 -Anesthetizing  the rabbits 
Rabbits were anesthetized by placing a piece of cotton over the nostrils and mouth 
socked with ether from BDH company and keep it in place until the animal was 
completely anesthetized and left it in place until the end of animal dissection. 
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12 -Aspiration  of blood 
After fully anesthetizing the animals, blood was withdrawn directly from the heart by 
inserting needle through the skin inferior and to left side of the xiphisternum and continue 
pushing until it reached the heart. As much as possible blood was withdrawn.About 1.8 
milliliter of fresh blood were added to 0.2 milliliter of sodium citrate for International 
Normalized Ratio (INR) study, and all remaining blood were left to clot in labelled plain 
tubes. Obtained sera were deeply freezedforlater biochemical studies of serum bilirubin, 
and serum liver enzymes (AST, ALT, ALP, and LDH), using special kits from Biosystem 
company and spectrophotometer. 
13 -Dissection  of rabbits 
While animal still fully anesthetized, dissection started by pining the legs to both sides 
and making midline incision using scalpel from xiphisternum to the pelvis. Opening ab- 
dominal wall was completed by scissor dissection. Then liver was removed and divided 
into two parts, one part left in 10% isotonic buffered formal-salinefor histopathologic 
examination, and second part of liver was taken fresh for homogenization in tissue ho- 
mogenizerand kept in deep freeze for further studies. 
 
14 -Grading of liver cell  injury 
Severity of liver injury was graded per serological examination into five grades depending 
on Council for International Organizations of Medical Sciences (CIOMS) toxicity scale 
[17]:Mild, 1+: Total serum bilirubin <2.5 mg/dl, and elevated serum levels of AST, ALT, 
or alkaline phosphatase, but without coagulopathy (INR <1.5).Moderate, 2+:Total serum 
bilirubin >2.5 mg/dl, and elevated levels of serum AST, ALT,  or alkaline phosphatase  
or both or coagulopathy (INR >1.5) without hyperbilirubinemia.Moderate to Severe, 
3+:Total serum bilirubin >2.5 mg/dl, and hospitalization and elevated serum levels of 
AST, ALT, or alkaline phosphatase.Severe, 4+:Total serum bilirubin >2.5 mg/dl, and ele- 
vated serum levels of AST, ALT, or alkaline phosphatase, and atleast one of the following: 
Prolonged jaundice, and symptoms beyond 3 months, or signs of hepatic decompensation 
(INR>1.5, ascites, encephalopathy), or other organ failure induced by the drug. Fatal, 
5+: causing death or need liver transplantation. 
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15 -Markers of oxidative stress in liver  cells 
Include estimation of Malodialdehyde (MDA), reduced glutathione (GSH), and 
superox- ide dismutase (SOD)in liver tissues homogenate by ELIZA technique using 
special kits from Biocusa company and fully automated Biotech ELIZA system. 
 
16 -Histopathological findings and Scores of liver cells 
injury 
Liver cell injury was ranked per extent of histopathological alterations found by 
examina- tion of ten high power fields into four scores according [20]:Score (0): No or 
very mild +/- histopathologicalchanges seen in < 5% of fields. Scoremild (+): when 
histopathological changes seen in >5% but < 20% of fields.Score mod- erate (++): 
histopathological changes seen in 20 to 60% of fields.Score severe(+++): 
histopathological changes seen in >60% of fields. 
17 -Statistical analysis 
The IBM SPSS version 24 statistical software and Microsoft Excel 2010 were used 
for statistical analysis. Numerical data results were formulated as mean and standard 
error. Comparison between two groups were carried out by t-test on data that were 
normally distributed. Non-parametric Mann-Whitney U test was carried out on data that 
were not normally distributed. The data were considered statistically significant when the 
(p-value) is below 0.05. 
 
18 -Results 
19 -Results of blood studies 
The levels of serum bilirubin, liver enzymes (AST, ALT, ALP, and LDH), INR were 
el- evated in methotrexate group as compared to these in the control group. While, these 
parameters were normal or very close to the normal ones in Curcumin group. Grading  
of liver cell injury depending on grading system using serological findings introduced by 
Council for International Organizations of Medical Sciences (CIOMS)toxicity scale can 
be summarized as follows: Methotrexate group one rabbit was mild grade +, three were 
moderate grade ++, and six were rabbits moderate to severe grade +++.Grading of liver 
cell injury in Curcumin group was one rabbit mild grade +, and nine was normal grade 
0. All results were statistically significant, and the p-values were < 0.05, table-1 and 
figures2&3. 
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20 -Results of oxidative markers in liver tissue homogenate 
Using ELIZA system from Biotech and kits from Biocusa company, the mean of 
MDAlevel liver tissue homogenate in methotrexate group was markedly elevated com- 
pare to control. There was also reduction in the levels of GSH and SOD which are 
intracellular antioxidant systems. While, in Curcumin group, the results of these markers 
were normal or very close to normal.  All the results were statistically significant with 
p-values<0.05, table 2, and figure 4. 
 
 
 
 
21 -Histopathologic Results and Scores of Liver Cells 
Injury 
Histopathological examination of the liver sections from methotrexate group showed 
acute hepatic injury of diffuse type. Scores of liver cells injury in methotrexate group 
accordingDavid E Kleiner [20]  were:  Score+ in one rabbit, Score++ in three rabbits, and 
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Score+++ in six rabbits. While sections from liver of rabbit in Curcumin group showed 
one rabbit with score+/0 (very mild), and Score 0 in other nine rabbits,figures 4-7. These 
findings agree with scores obtained by serological tests by CIOMS method shown in 
figure-5. All results were statistically significant with p-values<0.05. 
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22 -Discussion 
Chemotherapeutic agents are widely used in treatment of varioushuman cancers [1]. 
Chemotherapeutic drugs are not working selectively on tumor cells, theyinterfere with 
physiologicalhomeostasis of cells in most of vital body organs in partic- ularly the liver, 
kidneys, hair forming cells, bone marrow producing cells and heart [2] [4]. Although, 
Methotrexate is one of the most efficient anticancer drug it has been reported to cause 
toxicity in liv- ers, hearts, kidneys, and cause hair loss [2] [4].The present study showed 
that methotrexate is a hepatotoxic drug. Hepatotoxicity of methotrexatewas shown by 
findingin Methotrexate group of abnormal levels of serum bilirubin, liver enzymes (AST, 
ALT, ALP, and LDH), INR, and confirmed by histopathological examination of liver 
sections. Findings from present study also showed that, total serum bilirubin, INR and 
serum liver enzymes are good markers for liver cells injury, because their levels 
correlate well with the scores of liver cells injury on histopathological examination. The 
more the liver cell damage seen on histopathology, the more the alterations in these serum 
parameters.The scores of liver cells injury depending on serum parameters, and per 
scoring system introduced by CIOMS [17], were scores were 0 in control group, in 
Methotrexate group one rabbit scored mild 1+, three moderate ++, and six moderate to 
severe +++.While in Curcumin group, one rabbit scored mild score +, and nine scored 0. 
These findings agree with other studies by [1] [18] [3]. Although the mechanism of 
methotrexate -induced liver toxicity is not en- tirely elucidatedbut in the present 
study,occurrence of oxidative stress ishighly suspected because of increased levels of 
MDA and decrease level of GSH and SOD in liver tissue homogenate.The MDA level is 
a marker for lipid peroxidation, while GSH and SOD are intracellular antioxidant 
systems [19].Results of present study showed MDA significantlyaccumulated in liver 
cells of methotrexate groupcompared to controls indicating membranes damage and 
lipid peroxidation because of oxidative stress and generation and accumulation of ROS 
induced by methotrexate administration. This finding agreed with previouslyreported 
studies by [7] [8] [9].The finding of reduced levels of SOD and GSH in liver tissue 
homogenates in the present were due to their uti- lization which again support oxidative 
stress and generation of ROS in the pathogenesis of methotrexate induced 
hepatotoxicity. This finding also agree with the same findings in studies by [7] [8] [9] 
[15] [17] [19].The histopathological scoring of liver cell injury depending on scoring 
method introduced [19] by David E Kleiner (2017) was in control group the score was 0, 
in Methotrexate group one rabbit scored mild score+, three moderate score ++, and six 
severe score +++ liver cell injury. Histopathological scoring in Curcumin group was one 
rabbit mild score +/-, and nine normal score 0. The histopathologic scoring result in the 
present study also correlates good with results of serological scoring system introduced 
by CIOMS toxicity scale.  These finding agreed with findings obtained in other studies 
by [19] [20] [21].Evaluation of whole results of serological parameters, liver tissue 
homogenate, scoring systems and liver tissue histopathology in the present study 
revealed liver cell injury and hepatoxicity in Methotrexate group, and normal or near 
normal in Curcumin group. These findings support Methotrexate induced hepatotoxicity 
and Curcumin hepatoprotective ability in reducing Methotrexate induced hepatic injury 
by itsantioxidant activity. These findings agreed with other studies by [14] [15] [16] 
[22] . 
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23 -Conclusion 
Inspite of being a potent chemotherapeutic agent,  methotrexate has a lot of side ef-  
fects including bone marrow suppression, hepatotoxicity, nephrotoxicity and hair loss. 
The mechanism of methotrexate toxicity is through oxidative stress and reactive oxygen 
species production. The deleterious effects of methotrexate can be reduced by concomi- 
tant administration of natural antioxidant especially Curcumin. Recommendation was to 
encourage the cancer patients to taken natural antioxidants herbs and food supplement 
especially Curcumin before, during and after the courses of chemotherapy. 
 
References 
[1] A. R. Moghadam, S. Tutunchi, A. Namvaran-Abbas-Abad, and M. Yazdi3, 
“Fatemeh bonyadi, daryoush mohajeri et al. pre-administration of turmeric 
preventsmethotrexate-induced liver toxicity andoxidative stress,” Complementary 
and Alternative, vol. 15, p. 246, 2015. [Online]. Available: 10.1186/s12906-015- 
0773-6 
[2] I. D. U. M. Steinman AJ, Gladman DD, “Prolonged serologically active clinically 
quiescent systemic lupus erythematosus: frequency and outcome,” J Rheumatol, 
vol. 37, pp. 1822–27, 2010. 
[3] R. Sakthiswary and E. Suresh, “Methotrexate in systemic lupus erythematosus: a 
systematic review of its efficacy,” Lupus, vol. 23, pp. 225–35, 2014. 
[4] Sakthiswary R, Suresh E, “Methotrexate in systemic lupus erythematosus: a 
systematic review of its efficacy,” Lupus, vol. 23, no. 23, pp. 225–35, 2014. 
[5] M. X.-B. Q. Y.-H. L. S.-F. Zhu H, Deng F-Y, “Pharmacogenetics andpharmacoge- 
nomics for rheumatoid arthritis responsiveness to methotrexatetreatment: Pharma- 
cogenomics,” Pharmacogenomics, vol. 15, pp. 551–66, 2014. 
[6] J. West, S. Ogston, C. Palmer, C. Fleming, V. K. R.Dawe, S. Waterston, and J. Foer- 
ster, “Methotrexate in psoriasis under real-world conditions: long-term efficacy and 
tolerability,” British Journal of Dermatology. June, vol. 174, no. 6, pp. 1407–10, 
2016. 
[7] P. T. Wong and S. K. Choi, “Mechanisms and implications of dual-acting 
methotrexatein folate-targeted nanotherapeutic delivery,” Int J Mol Sci, vol. 16, pp. 
1772–90, 2015. [Online]. Available: 10.3390/ijms16011772 
[8] K. F. A. M. Gilani ST, Khan DA, “Adverse effects of low dose methotrexate in 
rheumatoid arthritis patients,” J Coll Physicians Surg Pak, vol. 22, no. 2, pp. 101–4, 
2012. [Online]. Available: 02.2012/JCPSP.101104 
[9] M. ASchwartz, “High-dose methotrexate for metastatic breast cancer to  the  
central  nervous  system:  A  single-institution  review  of  46  patients.”  Journal  
of Clinical Oncology, vol. 32, no. 5, pp. 1079–89, 2014. [Online]. Available: 
10.1200/jco.2014.32.15\_suppl 
 
116 156 
Journal of University of Babylon, Pure and Applied Sciences,Vol.(26), No.(5): 2018 
 
107 
 
 
[10] A. E. Kela, P. Stegmaierc, T. Valeevb, J. Koschmannc, V. Poroikove, and O. V. Kel- 
Margoulisc, “et al.multi-omics “upstream analysis” of regulatory genomic regions 
helps identifying targets against methotrexate resistance of colon cancer,” Journal 
Data in Brief., vol. 10, pp. 499–04, 2017. 
[11] A. A. S. Ralf Paus, Iain S Haslam and V. A. Botchkarev, “Pathobiology of 
chemotherapy-induced hair loss,” The Lancet Oncology, vol. 14, no. 2, pp. 50–9, 
2013. 
[12] I. Pountos and P. V. Giannoudis, “Effect of methotrexate on bone and wound heal- 
ing,” Journal Expert Opinion on Drug Safety, pp. 1–11, 2017. 
[13] C. E. Z. D. G. T. Sami Akbulut, Hulya Elbe and E. O. et al., “Cytoprotective ef- 
fects of amifostine, ascorbic acid and n-acetylcysteine against methotrexate-induced 
hepatotoxicity in rats,” World J Gastroenterol, vol. 20, no. 29, pp. 10 158–10 165, 
2014. 
[14] A. H. M. S. H. Seyed Fazel Nabavi, Maria Daglia and S. M. Nabavi, “Curcumin and 
liver disease: from chemistry to medicine,” Comprehensive Reviewsin Food Science 
and Food Safety, vol. 13, 2014. 
[15] R. S. Y. P. H. L.-Y. C. Bao W,  Li K and N. A. e. a. Zhang X, “Curcumin allevi-  
ates the ethanol-induced hepatocytes oxidativedamageinvolving heme oxygenase-1 
induction,” J Ethnopharmacol, vol. 128, pp. 549–53, 2010. 
[16] S. C. Gupta, S. Patchva, and B. B. Aggarwal, “Therapeutic roles of curcumin: 
Lessons learned from clinical trials,” The AAPS Journal, vol. 15, p. 1, 2013. 
[17] J. C. W. M. Huihui Donga, Douglas Slainc and W. Lianga, “Eighteen cases of liver 
injury following ingestion of polygonum multiflorum.” Complementary Therapies 
in Medicine, vol. 22, no. 1, pp. 70–74, 2014. 
[18] W. T. D. A. B. J. S. C. Maybury CM, Jabbar-Lopez ZK, “Methotrexate and liver 
fibrosis in people with psoriasis: a systematic review of observational studies.” Br J 
Dermatol, vol. 171, no. 1, pp. 17–29, 2014. 
[19] D.  E.  Kleiner,  “The  histopathological  evaluation  of  drug-induced  liver injury.” 
Histopathology, vol. 70, no. 1, pp. 81–93, 2015. 
[20] J. M. Crowford,  “Evidence-based interpretation of liver biopsies,”  Lab Invest,  
vol. 86, pp. 326–34, 2006. 
[21] M. M. Skelly, P. D. Lames, and S. D. Ryder, “Finding on liver biopsy to investi- 
gate abnormal liver function test in the absence of diagnostic serology,” J Hepatol, 
vol. 35, pp. 195–209, 2001. 
[22] S. M. S. B. A. V. Ruptanu Banerjee, Mrinmoy Dey and U. S. et al, “Preventive role 
of curcumin against hepatotoxic effects of methotrexate and cyclophosphamide,” 
Journal of Chemical and Pharmaceutical Sciences., no. Special Issue (4), pp. 38– 
41, 2016, issue (4) Pages: 38 – 41. 
117 157 
